The Drug Science Podcast

Professor David Nutt has spent a career making the argument for a rational, evidence-based approach to drug policy and drug use. The scientific evidence still challenges perceived wisdom on drugs and for that reason can appear to be contentious. In this podcast, the Professor explores the actual harms and potential benefits of various drugs, challenging myths surrounding classification and legislation, and exploring the societal impact of poorly informed drug policy. Using evidence in public policy should not be controversial. A podcast for anyone interested in understanding the scientific truth about drugs, free from political or moral concern.

https://drugscience.org.uk/

subscribe
share






episode 72: 72. The Student Society Network with Libby Furminger and Ben Clayden


Libby and Ben are third-year students from Swansea University and the University of York, who are deeply interested in the use of psychedelics in medicine and drug policy. At their universities, they are presidents of their respective Psychedelics in Medicine societies which raise awareness on the therapeutic potential of psychedelic drugs among fellow students. Tune in to the episode to find out about their journeys into the world of Drug Science and how to get involved yourself! 

 

Get in touch with the Student Society Network! 

Find out more about the Drug Science Student Society Network 

Psychedelics in Medicine Podcast

 

Serotonin

Neuroscientifically Challenged

Psilocybin 

LSD

Ben Sessa

MDMA

MDMA and psychotherapy in alcohol dependence treatment

Brain on LSD imaging

Psycare

Drugs Harm Scale

Project Twenty21

Drug Science Student Society Network

Brain and Mind Made Simple by David Nutt

UK Patient Conference: Medical Cannabis Awareness Week 2022

Medical cannabis awareness week 

Anything Can Happen

Secondary School Education Resources

Transform Drugs

Anyone’s Child

Misuse of Drugs Act 1971

Harm Reduction

★ Support this podcast ★


fyyd: Podcast Search Engine
share








 September 14, 2022  37m